Atıf Formatları
Serum M65 as a biomarker for metastatic renal cell carcinoma.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

İ. YILDIZ Et Al. , "Serum M65 as a biomarker for metastatic renal cell carcinoma.," Clinical genitourinary cancer , vol.11, no.3, pp.290-6, 2013

YILDIZ, İ. Et Al. 2013. Serum M65 as a biomarker for metastatic renal cell carcinoma.. Clinical genitourinary cancer , vol.11, no.3 , 290-6.

YILDIZ, İ., Sen, F., Kilic, L., Keskin, S., DURANYILDIZ, H. D., Bilgin, E., ... Disci, R.(2013). Serum M65 as a biomarker for metastatic renal cell carcinoma.. Clinical genitourinary cancer , vol.11, no.3, 290-6.

YILDIZ, İBRAHİM Et Al. "Serum M65 as a biomarker for metastatic renal cell carcinoma.," Clinical genitourinary cancer , vol.11, no.3, 290-6, 2013

YILDIZ, İBRAHİM Et Al. "Serum M65 as a biomarker for metastatic renal cell carcinoma.." Clinical genitourinary cancer , vol.11, no.3, pp.290-6, 2013

YILDIZ, İ. Et Al. (2013) . "Serum M65 as a biomarker for metastatic renal cell carcinoma.." Clinical genitourinary cancer , vol.11, no.3, pp.290-6.

@article{article, author={İBRAHİM YILDIZ Et Al. }, title={Serum M65 as a biomarker for metastatic renal cell carcinoma.}, journal={Clinical genitourinary cancer}, year=2013, pages={290-6} }